238 related articles for article (PubMed ID: 30759271)
1. Prognostic significance of BAP1 expression in high-grade upper tract urothelial carcinoma: a multi-institutional study.
Aydin AM; Singla N; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Westerman ME; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V; Krabbe LM
World J Urol; 2019 Nov; 37(11):2419-2427. PubMed ID: 30759271
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of decreased E-cadherin expression in patients with upper tract urothelial carcinoma: a multi-institutional study.
Favaretto RL; Bahadori A; Mathieu R; Haitel A; Grubmüller B; Margulis V; Karam JA; Rouprêt M; Seitz C; Karakiewicz PI; Cunha IW; Zequi SC; Wood CG; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Jacquet-Kammerer S; Bensalah K; Lotan Y; Bachmann A; Rink M; Briganti A; Shariat SF
World J Urol; 2017 Jan; 35(1):113-120. PubMed ID: 27129576
[TBL] [Abstract][Full Text] [Related]
3. The expression of urokinase-type plasminogen activator system in upper tract urothelial carcinoma and its prognostic value after radical nephroureterectomy.
Abufaraj M; Kimura S; Haitel A; Iwata T; Isleem U; D'Andrea D; Soria F; Mori K; Rink M; Bensalah K; Rouprêt M; Margulis V; Briganti A; Karakiewicz PI; Shariat SF
Urol Oncol; 2020 Aug; 38(8):685.e17-685.e25. PubMed ID: 32381392
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Impact of Preoperative Albumin-Globulin Ratio on Oncologic Outcomes in Upper Tract Urothelial Carcinoma Treated With Radical Nephroureterectomy.
Xu H; Tan P; Ai J; Huang Y; Lin T; Yang L; Wei Q
Clin Genitourin Cancer; 2018 Oct; 16(5):e1059-e1068. PubMed ID: 29980449
[TBL] [Abstract][Full Text] [Related]
5. Multi-institutional evaluation of the prognostic significance of EZH2 expression in high-grade upper tract urothelial carcinoma.
Singla N; Krabbe LM; Aydin AM; Panwar V; Woldu SL; Freifeld Y; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Rioux-Leclercq N; Haitel A; Roscigno M; Bolenz C; Bensalah K; Sagalowsky AI; Shariat SF; Lotan Y; Bagrodia A; Kapur P; Margulis V
Urol Oncol; 2018 Jul; 36(7):343.e1-343.e8. PubMed ID: 29748098
[TBL] [Abstract][Full Text] [Related]
6. Impact of tumour size on prognosis of upper urinary tract urothelial carcinoma after radical nephroureterectomy: a multi-institutional analysis of 795 cases.
Shibing Y; Liangren L; Qiang W; Hong L; Turun S; Junhao L; Lu Y; Zhengyong Y; Yonghao J; Guangqing F; Yunxiang L; Dehong C
BJU Int; 2016 Dec; 118(6):902-910. PubMed ID: 26935344
[TBL] [Abstract][Full Text] [Related]
7. Androgen receptor expression is associated with adverse pathological features in ureteral but not in pelvicalyceal urothelial carcinomas of the upper urinary tract.
Wirth GJ; Haitel A; Moschini M; Soria F; Klatte T; Hassler MR; Bensalah K; Briganti A; Karam JA; Lotan Y; Margulis V; Raman JD; Remzi M; Rioux-Leclercq N; Robinson BD; Rouprêt M; Wood CG; Shariat SF
World J Urol; 2017 Jun; 35(6):943-949. PubMed ID: 27730305
[TBL] [Abstract][Full Text] [Related]
8. Prospective analysis of Ki-67 as an independent predictor of oncologic outcomes in patients with high grade upper tract urothelial carcinoma.
Krabbe LM; Bagrodia A; Lotan Y; Gayed BA; Darwish OM; Youssef RF; John G; Harrow B; Jacobs C; Gaitonde M; Sagalowsky AI; Shariat SF; Kapur P; Margulis V
J Urol; 2014 Jan; 191(1):28-34. PubMed ID: 23871758
[TBL] [Abstract][Full Text] [Related]
9. Association between lymphovascular invasion and oncological outcome in node-negative upper tract urothelial carcinoma with different stage.
Chen CS; Lin CY; Wang CL; Wang SS; Li JR; Yang CK; Cheng CL; Chiu KY; Yang SF
Urol Oncol; 2021 Feb; 39(2):132.e13-132.e26. PubMed ID: 32900630
[TBL] [Abstract][Full Text] [Related]
10. Prognostic role of ERCC1 protein expression in upper tract urothelial carcinoma following radical nephroureterectomy with curative intent.
Mbeutcha A; Lucca I; Margulis V; Karam JA; Wood CG; de Martino M; Mathieu R; Haitel A; Xylinas E; Kluth L; Rouprêt M; Karakiewicz PI; Briganti A; Rink M; Rieken M; Weizer AZ; Raman JD; Rioux-Leclecq N; Bolenz C; Bensalah K; Lotan Y; Seitz C; Remzi M; Shariat SF; Klatte T
World J Urol; 2016 Aug; 34(8):1155-61. PubMed ID: 26658888
[TBL] [Abstract][Full Text] [Related]
11. Altered Expression of the Transcription Factor Forkhead Box A1 (FOXA1) Is Associated With Poor Prognosis in Urothelial Carcinoma of the Upper Urinary Tract.
Raman JD; Warrick JI; Caruso C; Yang Z; Shuman L; Bruggeman RD; Shariat S; Karam JA; Wood C; Weizer AZ; Remzi M; Haitel A; Bensalah K; Rioux-Leclerq N; Bolenz C; Roscigno M; Krabbe LM; Kapur P; Lotan Y; Margulis V; DeGraff DJ
Urology; 2016 Aug; 94():314.e1-7. PubMed ID: 27215483
[TBL] [Abstract][Full Text] [Related]
12. Promising role of preoperative neutrophil-to-lymphocyte ratio in patients treated with radical nephroureterectomy.
Vartolomei MD; Mathieu R; Margulis V; Karam JA; Rouprêt M; Lucca I; Mbeutcha A; Seitz C; Karakiewicz PI; Fajkovic H; Wood CG; Weizer AZ; Raman JD; Rioux-Leclercq N; Haitel A; Bensalah K; Rink M; Briganti A; Xylinas E; Shariat SF
World J Urol; 2017 Jan; 35(1):121-130. PubMed ID: 27209168
[TBL] [Abstract][Full Text] [Related]
13. Pathologic stage as a surrogate for oncologic outcomes after receipt of neoadjuvant chemotherapy for high-grade upper tract urothelial carcinoma.
Singla N; Christie A; Freifeld Y; Ghandour RA; Woldu SL; Clinton TN; Petros FG; Robyak H; Yeh HC; Fang D; Enikeev D; Bagrodia A; Sagalowsky AI; Lotan Y; Raman JD; Matin SF; Margulis V
Urol Oncol; 2020 Dec; 38(12):933.e7-933.e12. PubMed ID: 32430254
[TBL] [Abstract][Full Text] [Related]
14. Laparoscopic radical nephroureterectomy is associated with worse survival outcomes than open radical nephroureterectomy in patients with locally advanced upper tract urothelial carcinoma.
Kim HS; Ku JH; Jeong CW; Kwak C; Kim HH
World J Urol; 2016 Jun; 34(6):859-69. PubMed ID: 26497823
[TBL] [Abstract][Full Text] [Related]
15. Insulin-like growth factor messenger RNA-binding protein 3 expression helps prognostication in patients with upper tract urothelial carcinoma.
Lee DJ; Xylinas E; Rieken M; Khani F; Klatte T; Wood CG; Karam JA; Weizer AZ; Raman JD; Remzi M; Guo CC; Rioux-Leclercq N; Haitel A; Bolenz C; Bensalah K; Sagalowsky AI; Montorsi F; Lotan Y; Shariat SF; Robinson BD; Margulis V
Eur Urol; 2014 Aug; 66(2):379-85. PubMed ID: 24388440
[TBL] [Abstract][Full Text] [Related]
16. High expression of Chitinase 3-like-1 is an unfavorable prognostic factor in urothelial carcinoma of upper urinary tract and urinary bladder.
Lee YE; Chan TC; Tian YF; Liang PI; Shiue YL; Chen YS; He HL
Urol Oncol; 2019 May; 37(5):299.e7-299.e18. PubMed ID: 30660494
[TBL] [Abstract][Full Text] [Related]
17. Association of perioperative blood transfusion with oncologic outcomes after radical nephroureterectomy for upper tract urothelial carcinoma.
Rieken M; Schubert T; Xylinas E; Kluth L; Rouprêt M; Trinh QD; Lee RK; Al Hussein Al Awamlh B; Fajkovic H; Novara G; Margulis V; Lotan Y; Martinez-Salamanca JI; Matsumoto K; Seitz C; Remzi M; Karakiewicz PI; Scherr DS; Briganti A; Bachmann A; Shariat SF;
Eur J Surg Oncol; 2014 Dec; 40(12):1693-9. PubMed ID: 24780094
[TBL] [Abstract][Full Text] [Related]
18. [Clinicopathologic characteristics and prognosis of upper tract urothelial carcinoma: an analysis of 368 radical nephroureterectomy specimens].
Wang Y; He HY
Zhonghua Bing Li Xue Za Zhi; 2016 Oct; 45(10):681-686. PubMed ID: 27760608
[No Abstract] [Full Text] [Related]
19. The prognostic value of BAP1, PBRM1, pS6, PTEN, TGase2, PD-L1, CA9, PSMA, and Ki-67 tissue markers in localized renal cell carcinoma: A retrospective study of tissue microarrays using immunohistochemistry.
Kim SH; Park WS; Park EY; Park B; Joo J; Joung JY; Seo HK; Lee KH; Chung J
PLoS One; 2017; 12(6):e0179610. PubMed ID: 28654655
[TBL] [Abstract][Full Text] [Related]
20. Degree of hydronephrosis predicts adverse pathological features and worse oncologic outcomes in patients with high-grade urothelial carcinoma of the upper urinary tract.
Chung PH; Krabbe LM; Darwish OM; Westerman ME; Bagrodia A; Gayed BA; Haddad AQ; Kapur P; Sagalowsky AI; Lotan Y; Margulis V
Urol Oncol; 2014 Oct; 32(7):981-8. PubMed ID: 25022858
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
